Español
Medicine is beginning to correct errors in the code of life
For decades, medicine has treated illnesses by attempting to manage symptoms or slow their progression. However, in recent years a much more profound approach has emerged: treating the disease at its source, directly at the DNA level.
Genetic editing techniques, particularly CRISPR, have ushered in a new era in biomedical research. And now, with more precise tools such as the With prime editing, science is beginning to explore something that, just a decade ago, seemed like science fiction: repairing genetic mutations within human cells.
The potential of these technologies is enormous, particularly in the case of rare diseases, hereditary conditions and certain types of cancer.
What is CRISPR and why has it revolutionised biomedicine?
CRISPR is a molecular tool that edit specific fragments of DNA.
It could be likened to a pair of ‘genetic scissors’ capable of locating a specific sequence in the genome and modifying it. Thanks to this technology, researchers can remove faulty genes, correct mutations or introduce new DNA sequences with a precision never seen before.
Since it was adapted for use in biomedical research, CRISPR has greatly accelerated the study of genetic diseases and has enabled the launch of numerous clinical trials in humans.
Prime editing: a new generation of genetic editing
Although CRISPR represented a huge leap forward, researchers have continued to refine the technology.
One of the tools most promising is CRISPR prime editing, an development of CRISPR which enables the introduction of changes that are very precise into the DNA without causing cuts through the entire genetic chain.
In simple terms, if CRISPR works like a pair of scissors, prime editing is more like a spellchecker capable of changing a specific letter within the genetic code.
This greater accuracy could reduce risks and increase the number of diseases that could be treated through genetic editing.
Which diseases could be treated using these technologies
Scientists are investigating the application of gene editing to a range of conditions, including:
- Sickle cell anaemia
- Beta-thalassaemia
- Some inherited immunodeficiencies
- Muscular dystrophies
- Rare metabolic disorders
In several cases, clinical trials have already shown promising results, suggesting that gene editing is beginning to move towards actual clinical practice.
A new era for personalised medicine
Genetic editing is also closely linked to the development of personalised medicine.
As our ability to analyse the human genome improves, it will become possible to design therapies targeted at specific mutations present in each patient.
Although technical, regulatory and ethical challenges remain, many researchers believe that we are witnessing one of the most transformative advances in modern medicine.
Frequently Asked Questions FAQ
What is CRISPR in medicine?
It is a technology for genetic editing which enables the modification of specific sequences of DNA in order to study or treat diseases.
What is the difference between CRISPR and prime editing?
Prime editing is an advancement of CRISPR that enables the modification of DNAprecision and without causing complete breaks in the genetic chain.
Which diseases could be treated using genetic editing?
Among the most widely studied are sickle cell anaemia, beta-thalassaemia, muscular dystrophies and certain inherited metabolic disorders.
Is gene editing already being used on patients?
Some therapies based on CRISPR have already reached advanced stages of clinical trials and in certain cases have been approved experimental treatments have been approved.
Is genetic editing safe?
Research continues to assess its safety and effectiveness, but new technologies are improving accuracy and reducing risks.
Sources
https://www.nature.com/articles/s41586-019-1711-4
https://crisprmedicinenews.com/clinical-trials/
https://www.statnews.com/2026/03/03/prime-medicine-seeks-fda-approval-cgd-disease-gene-editing-treatment/